Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centers

Overview of attention for article published in Clinical Sarcoma Research, August 2020

Altmetric Badge

About this Attention Score

Among the highest-scoring outputs from this source (#36 of 103)
Above-average Attention Score compared to outputs of the same age (53rd percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 8,776 followers.

RT @SuzieSiegel: From @Robertasanfili @casali_pg & colleages in Milan: Anthracycline-based adjuvant chemo for stage I uterine #leiomyosa…

Reply Repost Favourite

RT @SuzieSiegel: From @Robertasanfili @casali_pg & colleages in Milan: Anthracycline-based adjuvant chemo for stage I uterine #leiomyosa…

Reply Repost Favourite

RT @SuzieSiegel: From @Robertasanfili @casali_pg & colleages in Milan: Anthracycline-based adjuvant chemo for stage I uterine #leiomyosa…

Reply Repost Favourite

From @Robertasanfili @casali_pg & colleages in Milan: Anthracycline-based adjuvant chemo for stage I uterine #leiomyosarcoma offers longer disease-free survival than gemcitabine-based. #sarcoma #gyncsm https://t.co/EAJOCDJKrw

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.